Evidence map›Paper›PMID 39929942›Full record

ArticleScientific reports2025

Machine learning prediction of breast cancer local recurrence localization, and distant metastasis after local recurrences.

Kristóf Attila Kovács, Csaba Kerepesi, Dalma Rapcsák, Lilla Madaras, Ákos Nagy, Anikó Takács, Magdolna Dank, Gyöngyvér Szentmártoni, Attila Marcell Szász, Janina Kulka and 1 more

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Kristóf Attila Kovács *Department of Pathology, Forensic and Insurance Medicine, Semmelweis University, Budapest, Hungary.
Csaba Kerepesi *HUN-REN Institute for Computer Science and Control (SZTAKI), Budapest, Hungary.
Dalma RapcsákNational Institute of Oncology, Budapest, Hungary.
Lilla MadarasDepartment of Pathology, Forensic and Insurance Medicine, Semmelweis University, Budapest, Hungary.
Ákos NagyDepartment of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary.
Anikó TakácsDepartment of Pathology, Forensic and Insurance Medicine, Semmelweis University, Budapest, Hungary.
Magdolna DankDepartment of Internal Medicine and Oncology, Semmelweis University, Budapest, Hungary.
Gyöngyvér SzentmártoniDepartment of Internal Medicine and Oncology, Semmelweis University, Budapest, Hungary.
Attila Marcell SzászDepartment of Internal Medicine and Oncology, Semmelweis University, Budapest, Hungary.
Janina KulkaDepartment of Pathology, Forensic and Insurance Medicine, Semmelweis University, Budapest, Hungary.
Anna Mária TőkésDepartment of Pathology, Forensic and Insurance Medicine, Semmelweis University, Budapest, Hungary. tokes.anna.maria@semmelweis.hu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Local recurrences (LR) can occur within residual breast tissue, chest wall, skin, or newly formed scar tissue. Artificial intelligence (AI) technologies can extract a wide range of tumor features from large datasets helping in oncological decision-making. Recently, machine learning (ML) models have been developed to predict breast cancer recurrence or distant metastasis (DM). However, there is still a lack of models that consider the localization of LR as a tumor feature. To address this gap, here, we analysed data from 154 patients including pathological, clinical, and follow-up data (with an average follow-up of 133.16 months) on both primary tumors (PT) and recurrences. By using ML methods we predicted the localization of LR and the occurrence of DM after LR. The performance (ROC AUC) of the best ML models was 0.75, and 0.69 for predicting LR in breast parenchyma, and surgical scar tissue, respectively, and 0.74 for predicting DM after LR. We identified recurrence localization, and the time elapsed between the detection of primary breast carcinoma and the recurrence, and adjuvant chemotherapy as the most important features associated with further DM. We conclude that combining traditional prognostic factors with ML may provide important tools in the risk assessment of patients with breast LR.

Indexed as

Breast NeoplasmsMachine LearningNeoplasm Recurrence, LocalAdultAgedFemaleHumansMiddle AgedNeoplasm MetastasisPrognosisROC CurveBreast cancerLocal recurrencesMachine learning

Identifiers

PMID39929942
PMCPMC11811162

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.